Literature DB >> 30191300

Response to: Choroidal thickness changes stratified by outcome in real-world treatment of diabetic macular edema.

António Campos1,2,3, Elisa J Campos4,5, Anália do Carmo5,6, Rufino Silva4,7,8.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30191300     DOI： 10.1007/s00417-018-4128-0

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN： 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  5 in total

1.  OPTICAL COHERENCE TOMOGRAPHY BASELINE PREDICTORS FOR INITIAL BEST-CORRECTED VISUAL ACUITY RESPONSE TO INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT IN EYES WITH DIABETIC MACULAR EDEMA: The CHARTRES Study.

Authors:  Ana R Santos; Miguel  Costa; Christian Schwartz; Dalila Alves; João Figueira; Rufino Silva; Jose G Cunha-Vaz
Journal:  Retina       Date:  2018-06       Impact factor: 4.256

2.  Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.

Authors:  John A Wells; Adam R Glassman; Allison R Ayala; Lee M Jampol; Lloyd Paul Aiello; Andrew N Antoszyk; Bambi Arnold-Bush; Carl W Baker; Neil M Bressler; David J Browning; Michael J Elman; Frederick L Ferris; Scott M Friedman; Michele Melia; Dante J Pieramici; Jennifer K Sun; Roy W Beck
Journal:  N Engl J Med       Date:  2015-02-18       Impact factor: 91.245

Review 3.  Viewing the choroid: where we stand, challenges and contradictions in diabetic retinopathy and diabetic macular oedema.

Authors:  António Campos; Elisa J Campos; João Martins; António Francisco Ambrósio; Rufino Silva
Journal:  Acta Ophthalmol       Date:  2016-08-22       Impact factor: 3.761

Review 4.  Efficacy of anti-VEGF and laser photocoagulation in the treatment of visual impairment due to diabetic macular edema: a systematic review and network meta-analysis.

Authors:  Stephane Régnier; William Malcolm; Felicity Allen; Jonathan Wright; Vladimir Bezlyak
Journal:  PLoS One       Date:  2014-07-16       Impact factor: 3.240

5.  Using Patient-Level Data to Develop Meaningful Cross-Trial Comparisons of Visual Impairment in Individuals with Diabetic Macular Edema.

Authors:  Sobha Sivaprasad; Stephane A Regnier; Franck Fajnkuchen; Jonathan Wright; Alan R Berger; Paul Mitchell; Michael Larsen
Journal:  Adv Ther       Date:  2016-03-07       Impact factor: 3.845
  5 in total
  1 in total

1.  Choroidal Vascularity Index as a Biomarker for Visual Response to Antivascular Endothelial Growth Factor Treatment in Diabetic Macular Edema.

Authors:  Ningxin Dou; Shanshan Yu; Ching-Kit Tsui; Boyu Yang; Jianqiang Lin; Xi Lu; Yue Xu; Benjuan Wu; Jinfeng Zhao; Xiaoling Liang
Journal:  J Diabetes Res       Date:  2021-11-26       Impact factor: 4.011
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.